Key Takeaways: Tata Consumer Products finished at ₹955.00, just ₹10.00 above the rounded annual low of ₹945, while the 52-week high remained higher at ₹1,283. Tata Consumer Products closed at ₹955.00, ₹5.00 above its opening
Key Takeaways: The ₹2,156.00 finish left Tata Consultancy Services ₹70.00 above the daily low and ₹48.00 below the high within a ₹118.00 session range. At ₹2,156.00, Tata Consultancy Services was ₹42.30 below its 50-day DMA
Key Takeaways: Sun Pharmaceutical Industries closed at ₹1,760.00, ₹4.00 above its opening quotation of ₹1,756, compared with a separately quoted daily change of +0.01%. Sun Pharmaceutical Industries's ₹1,760.00 finish was ₹4.0
Key Takeaways: The ₹959.10 finish left State Bank of India ₹21.10 above the daily low and ₹0.90 below the high within a ₹22.00 session range. At ₹959.10, State Bank of India was ₹43.20 below its 50-day DMA of ₹1,002.30 and
Key Takeaways: Six-month performance of -8.09% differed from Shriram Finance's annual return of +41.02% by 49.11 percentage points, while the one-month figure was -8.61%. The ₹940.45 finish left Shriram Finance ₹19.45 above the dail
Key Takeaways: The ₹1,684.60 finish left SBI Life Insurance Company ₹12.60 above the daily low and ₹23.40 below the high within a ₹36.00 session range. SBI Life Insurance Company closed at ₹1,684.60, ₹6.60 above its opening
Key Takeaways: Reliance Industries closed at ₹1,170.30, ₹8.70 below its opening quotation of ₹1,179, compared with a separately quoted daily change of -0.65%. Reliance Industries finished at ₹1,170.30, just ₹10.30 above the ro
Key Takeaways: Power Grid Corporation of India closed at ₹249.15, ₹3.15 above its opening quotation of ₹246, compared with a separately quoted daily change of +1.84%. Power Grid Corporation of India finished at ₹249.15, just ₹
Key Takeaways: Oil & Natural Gas Corporation finished at ₹221.27, just ₹2.27 above the rounded annual low of ₹219, while the 52-week high remained higher at ₹308. The ₹221.27 finish left Oil & Natural Gas Corporation â
Indian stock market on Friday, October 9, saw a steep rebound after sharp sell-off in previous session. The bounce was a relief for investors but sentiment is still being weighed down by rising crude oil prices, foreign investor selling and tighter m
Max Healthcare shares rose on October 9 after the National Pharmaceutical Pricing Authority approved in principle a proposal to cap trade margins for identified non-scheduled anti-cancer drugs at 30% of the maximum retail price. The covered-drug list
Mahindra & Mahindra Financial Services has retained its top credit ratings across a wide range of borrowing programmes, with CRISIL Ratings, India Ratings & Research and CARE Ratings reaffirming their assessments of the company. The
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*